SCDLETRACS 2x Leveraged US Dividend Factor TR ETN
Provides 2x leveraged long exposure to the compounded quarterly performance of the Dow Jones US Dividend 100 TR USD Index.
By UBS · Launched 2021
0.95%
#4,684 of 5,562 · expensive
$8M
#4,850 of 5,562 · small
+41.8%
5 years
#2,304 of 5,562 · seasoned
Performance
Total-return NAV · USDTotal-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundAsset class
EquityRegion
North americaStrategy
Leveraged
Factor
Dividend
Index tracked
Dow Jones US Dividend 100 Total Return USD
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsYear-on-year price swings
Worst peak-to-trough loss
Where to buy
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Provides 2x leveraged long exposure to the compounded quarterly performance of the Dow Jones US Dividend 100 TR USD Index.
- Strategy
- Provides 2x leveraged long exposure to the Dow Jones US Dividend 100 TR USD Index — 100 high dividend-paying U.S. companies (excluding REITs) selected on consistent dividend history and fundamental strength. Leverage resets on a compounded quarterly basis (more frequently on Loss Rebalancing Events), less an Accrued Tracking Fee and financing costs.
- Inception date
- February 5, 2021
- Fund family
- UBS
Similar ETFs
Closest matches by profileOur take
Structural notes on how this fund behaves. Read our guide on the 6 warning signs.
Leveraged ETF — not a long-term hold
This fund uses leverage to amplify daily returns (e.g. 2x or 3x of an index). Daily rebalancing creates volatility decay — over weeks and months, the fund's return drifts from the stated multiple. In trending markets with low realised volatility, leveraged index ETFs can outperform their nominal multiple; in sideways or volatile markets they bleed. Designed for short-term tactical use, not buy-and-hold.
Source: Cheng & Madhavan, 'The Dynamics of Leveraged and Inverse ETFs' (2009)
Why we flagged this: strategy=leveraged + leveraged_name_or_strategy
Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More
What's next?
You've reviewed SCDL. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19